�ݺ�ߣshows by User: sureshrewar

�ݺ�ߣshows by User: sureshrewar / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: sureshrewar / Wed, 24 Jun 2015 04:25:00 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: sureshrewar 40 mystery' disease which kills attack in nigeria /slideshow/40-mystery-disease-which-kills-attack-in-nigeria/49766374 40mysterydiseasewhichkillsattackinnigeria-150624042500-lva1-app6892
]]>
]]> Wed, 24 Jun 2015 04:25:00 GMT /slideshow/40-mystery-disease-which-kills-attack-in-nigeria/49766374 sureshrewar@slideshare.net(sureshrewar) 40 mystery' disease which kills attack in nigeria sureshrewar <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/40mysterydiseasewhichkillsattackinnigeria-150624042500-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds" />

40 mystery' disease which kills attack in nigeria from Suresh Rewar

]]> 174 3 https://cdn.slidesharecdn.com/ss_thumbnails/40mysterydiseasewhichkillsattackinnigeria-150624042500-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 39. memingococcal meningitis /slideshow/39-memingococcal-meningitis/49766370 39-150624042450-lva1-app6891
Meningococcal disease is a severe illness with high case fatality (5-10%) and frequent sequelae. Meningococcal meningitis is a major cause of morbidity and mortality in the meningitis belt. Meningococcal disease is a major public health challenge in countries of sub-Saharan Africa lying in the meningitis belt. Human infections caused by meningococcal (Neisseria meningitidis) remain a serious health problem, infecting 500,000 to 1.2 million people and killing between 50,000 and 135,000 per year worldwide. The causative agent, Neisseria meningitidis normally lives in a commensal relationship with humans, colonizing the nasopharynx, and is transmitted between healthy persons by close contact. The most common symptoms are a stiff neck, high fever, sensitivity to light, confusion, headaches and vomiting. Low meningitis thresholds improve timely detection of epidemics. The diagnosis of meningococcal meningitis is confirmed by cerebrospinal fluid pleocytosis, Gram stain, polymerase chain reaction, culture of cerebrospinal fluid. Meningococcal disease can be treated with a number of effective antibiotics. It is important that treatment be started as soon as possible. If meningococcal disease is suspected, antibiotics are given right away. Antibiotics effective for this purpose include rifampicin, ciprofloxacin, ceftriaxone or azithromycin. Currently available meningococcal vaccines include polysaccharide vaccines against serogroups A, C, W135 & Y and newer protein polysaccharide conjugate vaccines against serogroup C. This review covers key aspects of the pathogenesis and management of meningococcal disease, as well as the very recent developments in disease epidemiology, outbreaks, and the evolution of meningococcal immunizations.]]>
Meningococcal disease is a severe illness with high case fatality (5-10%) and frequent sequelae. Meningococcal meningitis is a major cause of morbidity and mortality in the meningitis belt. Meningococcal disease is a major public health challenge in countries of sub-Saharan Africa lying in the meningitis belt. Human infections caused by meningococcal (Neisseria meningitidis) remain a serious health problem, infecting 500,000 to 1.2 million people and killing between 50,000 and 135,000 per year worldwide. The causative agent, Neisseria meningitidis normally lives in a commensal relationship with humans, colonizing the nasopharynx, and is transmitted between healthy persons by close contact. The most common symptoms are a stiff neck, high fever, sensitivity to light, confusion, headaches and vomiting. Low meningitis thresholds improve timely detection of epidemics. The diagnosis of meningococcal meningitis is confirmed by cerebrospinal fluid pleocytosis, Gram stain, polymerase chain reaction, culture of cerebrospinal fluid. Meningococcal disease can be treated with a number of effective antibiotics. It is important that treatment be started as soon as possible. If meningococcal disease is suspected, antibiotics are given right away. Antibiotics effective for this purpose include rifampicin, ciprofloxacin, ceftriaxone or azithromycin. Currently available meningococcal vaccines include polysaccharide vaccines against serogroups A, C, W135 & Y and newer protein polysaccharide conjugate vaccines against serogroup C. This review covers key aspects of the pathogenesis and management of meningococcal disease, as well as the very recent developments in disease epidemiology, outbreaks, and the evolution of meningococcal immunizations.]]> Wed, 24 Jun 2015 04:24:50 GMT /slideshow/39-memingococcal-meningitis/49766370 sureshrewar@slideshare.net(sureshrewar) 39. memingococcal meningitis sureshrewar Meningococcal disease is a severe illness with high case fatality (5-10%) and frequent sequelae. Meningococcal meningitis is a major cause of morbidity and mortality in the meningitis belt. Meningococcal disease is a major public health challenge in countries of sub-Saharan Africa lying in the meningitis belt. Human infections caused by meningococcal (Neisseria meningitidis) remain a serious health problem, infecting 500,000 to 1.2 million people and killing between 50,000 and 135,000 per year worldwide. The causative agent, Neisseria meningitidis normally lives in a commensal relationship with humans, colonizing the nasopharynx, and is transmitted between healthy persons by close contact. The most common symptoms are a stiff neck, high fever, sensitivity to light, confusion, headaches and vomiting. Low meningitis thresholds improve timely detection of epidemics. The diagnosis of meningococcal meningitis is confirmed by cerebrospinal fluid pleocytosis, Gram stain, polymerase chain reaction, culture of cerebrospinal fluid. Meningococcal disease can be treated with a number of effective antibiotics. It is important that treatment be started as soon as possible. If meningococcal disease is suspected, antibiotics are given right away. Antibiotics effective for this purpose include rifampicin, ciprofloxacin, ceftriaxone or azithromycin. Currently available meningococcal vaccines include polysaccharide vaccines against serogroups A, C, W135 & Y and newer protein polysaccharide conjugate vaccines against serogroup C. This review covers key aspects of the pathogenesis and management of meningococcal disease, as well as the very recent developments in disease epidemiology, outbreaks, and the evolution of meningococcal immunizations. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/39-150624042450-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds" /> Meningococcal disease is a severe illness with high case fatality (5-10%) and frequent sequelae. Meningococcal meningitis is a major cause of morbidity and mortality in the meningitis belt. Meningococcal disease is a major public health challenge in countries of sub-Saharan Africa lying in the meningitis belt. Human infections caused by meningococcal (Neisseria meningitidis) remain a serious health problem, infecting 500,000 to 1.2 million people and killing between 50,000 and 135,000 per year worldwide. The causative agent, Neisseria meningitidis normally lives in a commensal relationship with humans, colonizing the nasopharynx, and is transmitted between healthy persons by close contact. The most common symptoms are a stiff neck, high fever, sensitivity to light, confusion, headaches and vomiting. Low meningitis thresholds improve timely detection of epidemics. The diagnosis of meningococcal meningitis is confirmed by cerebrospinal fluid pleocytosis, Gram stain, polymerase chain reaction, culture of cerebrospinal fluid. Meningococcal disease can be treated with a number of effective antibiotics. It is important that treatment be started as soon as possible. If meningococcal disease is suspected, antibiotics are given right away. Antibiotics effective for this purpose include rifampicin, ciprofloxacin, ceftriaxone or azithromycin. Currently available meningococcal vaccines include polysaccharide vaccines against serogroups A, C, W135 & Y and newer protein polysaccharide conjugate vaccines against serogroup C. This review covers key aspects of the pathogenesis and management of meningococcal disease, as well as the very recent developments in disease epidemiology, outbreaks, and the evolution of meningococcal immunizations.

39. memingococcal meningitis from Suresh Rewar

]]> 248 3 https://cdn.slidesharecdn.com/ss_thumbnails/39-150624042450-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 5. swine flu influenza viruses a (h1 n1) /slideshow/5-swine-flu-influenza-viruses-a-h1-n1/49766170 5-150624041513-lva1-app6891
Flu viruses have mainly affected humans, birds and pigs worldwide. Influenza A viruses is highly infectious respiratory pathogens that can infect many species. The swine flu H1N1 reassorted subtype caused the first global pandemic in last 40 years, resulting in substantial illness, hospitalizations of millions of peoples and thousands of deaths throughout the world. There is no direct evidence that the reassortment events culminating in the 1918, 1957 or 1968 pandemic influenza viruses originated from pigs. Genetic reassortment among avian, human and/or swine influenza virus gene segments has occurred in pigs and some novel reassortant swine viruses have been transmitted to humans. The WHO declared the H1N1 pandemic on June 11, 2009, after more than 70 countries reported 30000 cases of H1N1 infection. Pandemic (H1N1) influenza most commonly causes a self-limited illness; however, significant morbidity and mortality were reported in the young, the obese and in pregnant women. The CDC recommends real time PCR as the method of choice for diagnosing H1N1. The U.S. Centers for Disease Control and Prevention recommends the use of Oseltamivir (Tamiflu) or Zanamivir (Relenza) for the treatment. The drugs of choice for treatment and prophylaxis of pandemic (H1N1) influenza are the neuraminidase inhibitors, Oseltamivir and Zanamivir. In this review, a brief overview on swine flu is presented highlighting the characteristics of the causative virus, the disease and its public health consequences, advances made in its diagnosis, vaccine and control to be adapted in the wake of an outbreak.]]>
Flu viruses have mainly affected humans, birds and pigs worldwide. Influenza A viruses is highly infectious respiratory pathogens that can infect many species. The swine flu H1N1 reassorted subtype caused the first global pandemic in last 40 years, resulting in substantial illness, hospitalizations of millions of peoples and thousands of deaths throughout the world. There is no direct evidence that the reassortment events culminating in the 1918, 1957 or 1968 pandemic influenza viruses originated from pigs. Genetic reassortment among avian, human and/or swine influenza virus gene segments has occurred in pigs and some novel reassortant swine viruses have been transmitted to humans. The WHO declared the H1N1 pandemic on June 11, 2009, after more than 70 countries reported 30000 cases of H1N1 infection. Pandemic (H1N1) influenza most commonly causes a self-limited illness; however, significant morbidity and mortality were reported in the young, the obese and in pregnant women. The CDC recommends real time PCR as the method of choice for diagnosing H1N1. The U.S. Centers for Disease Control and Prevention recommends the use of Oseltamivir (Tamiflu) or Zanamivir (Relenza) for the treatment. The drugs of choice for treatment and prophylaxis of pandemic (H1N1) influenza are the neuraminidase inhibitors, Oseltamivir and Zanamivir. In this review, a brief overview on swine flu is presented highlighting the characteristics of the causative virus, the disease and its public health consequences, advances made in its diagnosis, vaccine and control to be adapted in the wake of an outbreak.]]> Wed, 24 Jun 2015 04:15:13 GMT /slideshow/5-swine-flu-influenza-viruses-a-h1-n1/49766170 sureshrewar@slideshare.net(sureshrewar) 5. swine flu influenza viruses a (h1 n1) sureshrewar Flu viruses have mainly affected humans, birds and pigs worldwide. Influenza A viruses is highly infectious respiratory pathogens that can infect many species. The swine flu H1N1 reassorted subtype caused the first global pandemic in last 40 years, resulting in substantial illness, hospitalizations of millions of peoples and thousands of deaths throughout the world. There is no direct evidence that the reassortment events culminating in the 1918, 1957 or 1968 pandemic influenza viruses originated from pigs. Genetic reassortment among avian, human and/or swine influenza virus gene segments has occurred in pigs and some novel reassortant swine viruses have been transmitted to humans. The WHO declared the H1N1 pandemic on June 11, 2009, after more than 70 countries reported 30000 cases of H1N1 infection. Pandemic (H1N1) influenza most commonly causes a self-limited illness; however, significant morbidity and mortality were reported in the young, the obese and in pregnant women. The CDC recommends real time PCR as the method of choice for diagnosing H1N1. The U.S. Centers for Disease Control and Prevention recommends the use of Oseltamivir (Tamiflu) or Zanamivir (Relenza) for the treatment. The drugs of choice for treatment and prophylaxis of pandemic (H1N1) influenza are the neuraminidase inhibitors, Oseltamivir and Zanamivir. In this review, a brief overview on swine flu is presented highlighting the characteristics of the causative virus, the disease and its public health consequences, advances made in its diagnosis, vaccine and control to be adapted in the wake of an outbreak. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/5-150624041513-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds" /> Flu viruses have mainly affected humans, birds and pigs worldwide. Influenza A viruses is highly infectious respiratory pathogens that can infect many species. The swine flu H1N1 reassorted subtype caused the first global pandemic in last 40 years, resulting in substantial illness, hospitalizations of millions of peoples and thousands of deaths throughout the world. There is no direct evidence that the reassortment events culminating in the 1918, 1957 or 1968 pandemic influenza viruses originated from pigs. Genetic reassortment among avian, human and/or swine influenza virus gene segments has occurred in pigs and some novel reassortant swine viruses have been transmitted to humans. The WHO declared the H1N1 pandemic on June 11, 2009, after more than 70 countries reported 30000 cases of H1N1 infection. Pandemic (H1N1) influenza most commonly causes a self-limited illness; however, significant morbidity and mortality were reported in the young, the obese and in pregnant women. The CDC recommends real time PCR as the method of choice for diagnosing H1N1. The U.S. Centers for Disease Control and Prevention recommends the use of Oseltamivir (Tamiflu) or Zanamivir (Relenza) for the treatment. The drugs of choice for treatment and prophylaxis of pandemic (H1N1) influenza are the neuraminidase inhibitors, Oseltamivir and Zanamivir. In this review, a brief overview on swine flu is presented highlighting the characteristics of the causative virus, the disease and its public health consequences, advances made in its diagnosis, vaccine and control to be adapted in the wake of an outbreak.

5. swine flu influenza viruses a (h1 n1) from Suresh Rewar

]]> 566 5 https://cdn.slidesharecdn.com/ss_thumbnails/5-150624041513-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 4. post traumatic stress disorder (ptsd) an overview /slideshow/4-post-traumatic-stress-disorder-ptsd-an-overview/49766167 4-150624041503-lva1-app6891
Post-traumatic stress disorder (PTSD) is a complex mental disorder with psychological and emotional components, caused by exposure to single or repeated extreme traumatic events found in war, terrorist attacks, natural or man-caused disasters, and by violent personal assaults and accidents. In recent years, armed conflicts in the Middle East have resulted in high rates of exposure to traumatic events. Despite the increasing demand of mental health care provision, ongoing violence limits conventional approaches of mental health care provision. Internet-based interventions for posttraumatic stress disorder (PTSD) have proved feasible and effective in Western countries, but their applicability and efficacy in war and conflict regions remains unknown. Despite clinical studies and improved understanding of the mechanisms of cellular damage, prevention and treatment strategies for patients with PTSD remain unsatisfactory. Posttraumatic stress disorder is a prevalent mental health problem associated with substantial psychiatric morbidity. To develop an improved plan for treating and impeding progression of PTSD, it is important to identify underlying biochemical changes that may play key role in the initiation and progression of these disorders.]]>
Post-traumatic stress disorder (PTSD) is a complex mental disorder with psychological and emotional components, caused by exposure to single or repeated extreme traumatic events found in war, terrorist attacks, natural or man-caused disasters, and by violent personal assaults and accidents. In recent years, armed conflicts in the Middle East have resulted in high rates of exposure to traumatic events. Despite the increasing demand of mental health care provision, ongoing violence limits conventional approaches of mental health care provision. Internet-based interventions for posttraumatic stress disorder (PTSD) have proved feasible and effective in Western countries, but their applicability and efficacy in war and conflict regions remains unknown. Despite clinical studies and improved understanding of the mechanisms of cellular damage, prevention and treatment strategies for patients with PTSD remain unsatisfactory. Posttraumatic stress disorder is a prevalent mental health problem associated with substantial psychiatric morbidity. To develop an improved plan for treating and impeding progression of PTSD, it is important to identify underlying biochemical changes that may play key role in the initiation and progression of these disorders.]]> Wed, 24 Jun 2015 04:15:02 GMT /slideshow/4-post-traumatic-stress-disorder-ptsd-an-overview/49766167 sureshrewar@slideshare.net(sureshrewar) 4. post traumatic stress disorder (ptsd) an overview sureshrewar Post-traumatic stress disorder (PTSD) is a complex mental disorder with psychological and emotional components, caused by exposure to single or repeated extreme traumatic events found in war, terrorist attacks, natural or man-caused disasters, and by violent personal assaults and accidents. In recent years, armed conflicts in the Middle East have resulted in high rates of exposure to traumatic events. Despite the increasing demand of mental health care provision, ongoing violence limits conventional approaches of mental health care provision. Internet-based interventions for posttraumatic stress disorder (PTSD) have proved feasible and effective in Western countries, but their applicability and efficacy in war and conflict regions remains unknown. Despite clinical studies and improved understanding of the mechanisms of cellular damage, prevention and treatment strategies for patients with PTSD remain unsatisfactory. Posttraumatic stress disorder is a prevalent mental health problem associated with substantial psychiatric morbidity. To develop an improved plan for treating and impeding progression of PTSD, it is important to identify underlying biochemical changes that may play key role in the initiation and progression of these disorders. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/4-150624041503-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds" /> Post-traumatic stress disorder (PTSD) is a complex mental disorder with psychological and emotional components, caused by exposure to single or repeated extreme traumatic events found in war, terrorist attacks, natural or man-caused disasters, and by violent personal assaults and accidents. In recent years, armed conflicts in the Middle East have resulted in high rates of exposure to traumatic events. Despite the increasing demand of mental health care provision, ongoing violence limits conventional approaches of mental health care provision. Internet-based interventions for posttraumatic stress disorder (PTSD) have proved feasible and effective in Western countries, but their applicability and efficacy in war and conflict regions remains unknown. Despite clinical studies and improved understanding of the mechanisms of cellular damage, prevention and treatment strategies for patients with PTSD remain unsatisfactory. Posttraumatic stress disorder is a prevalent mental health problem associated with substantial psychiatric morbidity. To develop an improved plan for treating and impeding progression of PTSD, it is important to identify underlying biochemical changes that may play key role in the initiation and progression of these disorders.

4. post traumatic stress disorder (ptsd) an overview from Suresh Rewar

]]> 557 3 https://cdn.slidesharecdn.com/ss_thumbnails/4-150624041503-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 3.novel emerging infections sars cov /slideshow/3novel-emerging-infections-sars-cov/49766164 3-150624041454-lva1-app6892
Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. A severe viral illness caused by a newly discovered coronavirus was first reported in the 2003. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, Coronaviruses are enveloped viruses with plus-stranded RNA genomes of 26-32 kb, the largest contiguous RNA genomes in nature. Symptoms of SARS include: high fever, cough pneumonia, breathing difficulties headache, chills, muscle aches and sore throat. According to the World Health Organization (WHO), From November 2002 to July 2003 a total of 8098 patients, in 25 countries, were affected by the atypical pneumonia which resulted in 774 deaths globally. The severe acute respiratory syndrome (SARS) is a febrile respiratory illness primarily transmitted by respiratory droplets or close personal contact. There are several laboratory tests used to detect SARS-CoV and other causes of respiratory illness. Many methods used in the treatment of viral infections have been only partially effective. For example, the standard treatment in HCV (with ribavirin and interferon-alpha) is effective in 50% of cases.]]>
Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. A severe viral illness caused by a newly discovered coronavirus was first reported in the 2003. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, Coronaviruses are enveloped viruses with plus-stranded RNA genomes of 26-32 kb, the largest contiguous RNA genomes in nature. Symptoms of SARS include: high fever, cough pneumonia, breathing difficulties headache, chills, muscle aches and sore throat. According to the World Health Organization (WHO), From November 2002 to July 2003 a total of 8098 patients, in 25 countries, were affected by the atypical pneumonia which resulted in 774 deaths globally. The severe acute respiratory syndrome (SARS) is a febrile respiratory illness primarily transmitted by respiratory droplets or close personal contact. There are several laboratory tests used to detect SARS-CoV and other causes of respiratory illness. Many methods used in the treatment of viral infections have been only partially effective. For example, the standard treatment in HCV (with ribavirin and interferon-alpha) is effective in 50% of cases.]]> Wed, 24 Jun 2015 04:14:54 GMT /slideshow/3novel-emerging-infections-sars-cov/49766164 sureshrewar@slideshare.net(sureshrewar) 3.novel emerging infections sars cov sureshrewar Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. A severe viral illness caused by a newly discovered coronavirus was first reported in the 2003. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, Coronaviruses are enveloped viruses with plus-stranded RNA genomes of 26-32 kb, the largest contiguous RNA genomes in nature. Symptoms of SARS include: high fever, cough pneumonia, breathing difficulties headache, chills, muscle aches and sore throat. According to the World Health Organization (WHO), From November 2002 to July 2003 a total of 8098 patients, in 25 countries, were affected by the atypical pneumonia which resulted in 774 deaths globally. The severe acute respiratory syndrome (SARS) is a febrile respiratory illness primarily transmitted by respiratory droplets or close personal contact. There are several laboratory tests used to detect SARS-CoV and other causes of respiratory illness. Many methods used in the treatment of viral infections have been only partially effective. For example, the standard treatment in HCV (with ribavirin and interferon-alpha) is effective in 50% of cases. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/3-150624041454-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds" /> Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. A severe viral illness caused by a newly discovered coronavirus was first reported in the 2003. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, Coronaviruses are enveloped viruses with plus-stranded RNA genomes of 26-32 kb, the largest contiguous RNA genomes in nature. Symptoms of SARS include: high fever, cough pneumonia, breathing difficulties headache, chills, muscle aches and sore throat. According to the World Health Organization (WHO), From November 2002 to July 2003 a total of 8098 patients, in 25 countries, were affected by the atypical pneumonia which resulted in 774 deaths globally. The severe acute respiratory syndrome (SARS) is a febrile respiratory illness primarily transmitted by respiratory droplets or close personal contact. There are several laboratory tests used to detect SARS-CoV and other causes of respiratory illness. Many methods used in the treatment of viral infections have been only partially effective. For example, the standard treatment in HCV (with ribavirin and interferon-alpha) is effective in 50% of cases.

3.novel emerging infections sars cov from Suresh Rewar

]]> 495 4 https://cdn.slidesharecdn.com/ss_thumbnails/3-150624041454-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 1. transmission of ebola virus disease an overview /slideshow/1-transmission-of-ebola-virus-disease-an-overview/49766153 1-150624041433-lva1-app6892
Ebola is a viral illness of which the initial symptoms can include a sudden fever, intense weakness, muscle pain and a sore throat, according to the World Health Organization (WHO). Airborne transmission of Ebola virus has been hypothesized but not demonstrated in humans. Ebola is not spread through the air or by water, or in general, by food. However, in Africa, Ebola may be spread as a result of handling bushmeat (wild animals hunted for food) and contact with infected bats. The disease infects humans through close contact with infected animals, including chimpanzees, fruit bats, and forest antelope. Ebola virus can be transmitted by direct contact with blood, bodily fluids, or skin of patients with or who died of Ebola virus disease. As of late October 2014, the World Health Organization reported 13,567 suspected cases and 4922 deaths, although the agency believes that this substantially understates the magnitude of the outbreak. Experimental vaccines and treatments for Ebola are under development, but they have not yet been fully tested for safety or effectiveness.]]>
Ebola is a viral illness of which the initial symptoms can include a sudden fever, intense weakness, muscle pain and a sore throat, according to the World Health Organization (WHO). Airborne transmission of Ebola virus has been hypothesized but not demonstrated in humans. Ebola is not spread through the air or by water, or in general, by food. However, in Africa, Ebola may be spread as a result of handling bushmeat (wild animals hunted for food) and contact with infected bats. The disease infects humans through close contact with infected animals, including chimpanzees, fruit bats, and forest antelope. Ebola virus can be transmitted by direct contact with blood, bodily fluids, or skin of patients with or who died of Ebola virus disease. As of late October 2014, the World Health Organization reported 13,567 suspected cases and 4922 deaths, although the agency believes that this substantially understates the magnitude of the outbreak. Experimental vaccines and treatments for Ebola are under development, but they have not yet been fully tested for safety or effectiveness.]]> Wed, 24 Jun 2015 04:14:33 GMT /slideshow/1-transmission-of-ebola-virus-disease-an-overview/49766153 sureshrewar@slideshare.net(sureshrewar) 1. transmission of ebola virus disease an overview sureshrewar Ebola is a viral illness of which the initial symptoms can include a sudden fever, intense weakness, muscle pain and a sore throat, according to the World Health Organization (WHO). Airborne transmission of Ebola virus has been hypothesized but not demonstrated in humans. Ebola is not spread through the air or by water, or in general, by food. However, in Africa, Ebola may be spread as a result of handling bushmeat (wild animals hunted for food) and contact with infected bats. The disease infects humans through close contact with infected animals, including chimpanzees, fruit bats, and forest antelope. Ebola virus can be transmitted by direct contact with blood, bodily fluids, or skin of patients with or who died of Ebola virus disease. As of late October 2014, the World Health Organization reported 13,567 suspected cases and 4922 deaths, although the agency believes that this substantially understates the magnitude of the outbreak. Experimental vaccines and treatments for Ebola are under development, but they have not yet been fully tested for safety or effectiveness. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/1-150624041433-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds" /> Ebola is a viral illness of which the initial symptoms can include a sudden fever, intense weakness, muscle pain and a sore throat, according to the World Health Organization (WHO). Airborne transmission of Ebola virus has been hypothesized but not demonstrated in humans. Ebola is not spread through the air or by water, or in general, by food. However, in Africa, Ebola may be spread as a result of handling bushmeat (wild animals hunted for food) and contact with infected bats. The disease infects humans through close contact with infected animals, including chimpanzees, fruit bats, and forest antelope. Ebola virus can be transmitted by direct contact with blood, bodily fluids, or skin of patients with or who died of Ebola virus disease. As of late October 2014, the World Health Organization reported 13,567 suspected cases and 4922 deaths, although the agency believes that this substantially understates the magnitude of the outbreak. Experimental vaccines and treatments for Ebola are under development, but they have not yet been fully tested for safety or effectiveness.

1. transmission of ebola virus disease an overview from Suresh Rewar

]]> 1248 6 https://cdn.slidesharecdn.com/ss_thumbnails/1-150624041433-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Cambridge english vocabulary /slideshow/cambridge-english-vocabulary/47318348 cambridgeenglishvocabulary-150423013524-conversion-gate02
]]>
]]> Thu, 23 Apr 2015 01:35:24 GMT /slideshow/cambridge-english-vocabulary/47318348 sureshrewar@slideshare.net(sureshrewar) Cambridge english vocabulary sureshrewar <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cambridgeenglishvocabulary-150423013524-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds" />

Cambridge english vocabulary from Suresh Rewar

]]> 263 1 https://cdn.slidesharecdn.com/ss_thumbnails/cambridgeenglishvocabulary-150423013524-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Basic english usage [oxford] /slideshow/basic-english-usage-oxford-47318302/47318302 basicenglishusageoxford-150423013325-conversion-gate02
]]>
]]> Thu, 23 Apr 2015 01:33:25 GMT /slideshow/basic-english-usage-oxford-47318302/47318302 sureshrewar@slideshare.net(sureshrewar) Basic english usage [oxford] sureshrewar <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/basicenglishusageoxford-150423013325-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds" />

Basic english usage [oxford] from Suresh Rewar

]]> 155 1 https://cdn.slidesharecdn.com/ss_thumbnails/basicenglishusageoxford-150423013325-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Mpharm syallbas /slideshow/mpharm-syallbas/47318203 mpharmsyallbas-150423012821-conversion-gate01
Mpharm syallbas]]>
Mpharm syallbas]]> Thu, 23 Apr 2015 01:28:21 GMT /slideshow/mpharm-syallbas/47318203 sureshrewar@slideshare.net(sureshrewar) Mpharm syallbas sureshrewar Mpharm syallbas <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/mpharmsyallbas-150423012821-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds" /> Mpharm syallbas

Mpharm syallbas from Suresh Rewar

]]> 316 1 https://cdn.slidesharecdn.com/ss_thumbnails/mpharmsyallbas-150423012821-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Oral Dispersible Tablets /slideshow/1oral-dispersible-tablets/42595637 1-141211025440-conversion-gate01
ORAL DISPERSIBLE TABLETS: AN OVERVIEW; DEVELOPMENT, TECHNOLOGIES AND EVALUATION]]>
ORAL DISPERSIBLE TABLETS: AN OVERVIEW; DEVELOPMENT, TECHNOLOGIES AND EVALUATION]]> Thu, 11 Dec 2014 02:54:40 GMT /slideshow/1oral-dispersible-tablets/42595637 sureshrewar@slideshare.net(sureshrewar) Oral Dispersible Tablets sureshrewar ORAL DISPERSIBLE TABLETS: AN OVERVIEW; DEVELOPMENT, TECHNOLOGIES AND EVALUATION <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/1-141211025440-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds" /> ORAL DISPERSIBLE TABLETS: AN OVERVIEW; DEVELOPMENT, TECHNOLOGIES AND EVALUATION

Oral Dispersible Tablets from Suresh Rewar

]]> 7180 7 https://cdn.slidesharecdn.com/ss_thumbnails/1-141211025440-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 RESEALED ERYTHROCYTES /slideshow/ijcrcps13/42595514 ijcrcps13-141211025026-conversion-gate02
RESEALED ERYTHROCYTES AS CARRIERS AND ITS APPLICATION IN THERAPY Review article]]>
RESEALED ERYTHROCYTES AS CARRIERS AND ITS APPLICATION IN THERAPY Review article]]> Thu, 11 Dec 2014 02:50:26 GMT /slideshow/ijcrcps13/42595514 sureshrewar@slideshare.net(sureshrewar) RESEALED ERYTHROCYTES sureshrewar RESEALED ERYTHROCYTES AS CARRIERS AND ITS APPLICATION IN THERAPY Review article <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ijcrcps13-141211025026-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds" /> RESEALED ERYTHROCYTES AS CARRIERS AND ITS APPLICATION IN THERAPY Review article

RESEALED ERYTHROCYTES from Suresh Rewar

]]> 708 3 https://cdn.slidesharecdn.com/ss_thumbnails/ijcrcps13-141211025026-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-sureshrewar-48x48.jpg?cb=1523585654 I am Confident,Honest Person Having Positive Attitude Towards the Responsibilities Given And Believes In The Team Work. https://cdn.slidesharecdn.com/ss_thumbnails/40mysterydiseasewhichkillsattackinnigeria-150624042500-lva1-app6892-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/40-mystery-disease-which-kills-attack-in-nigeria/49766374 40 mystery' disease wh... https://cdn.slidesharecdn.com/ss_thumbnails/39-150624042450-lva1-app6891-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/39-memingococcal-meningitis/49766370 39. memingococcal meni... https://cdn.slidesharecdn.com/ss_thumbnails/5-150624041513-lva1-app6891-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/5-swine-flu-influenza-viruses-a-h1-n1/49766170 5. swine flu influenza...